$RGEN Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in REPLIGEN CORP.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in REPLIGEN CORP. Get notifications about new insider transactions in REPLIGEN CORP for free.

Page: < prev 1 2 3 4 5 6 ... 7 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
May 15 2020	RGEN	REPLIGEN CORP	KURIYEL RALF	Senior VP, R&D	Sell	S	126.88	1,612	204,531	32,912	34.5 K to 32.9 K (-4.67 %)
May 15 2020	RGEN	REPLIGEN CORP	KURIYEL RALF	Senior VP, R&D	Buy	M	33.87	2,000	67,740	34,524	32.5 K to 34.5 K (+6.15 %)
May 15 2020	RGEN	REPLIGEN CORP	KURIYEL RALF	Senior VP, R&D	Buy	M	33.05	6,000	198,300	32,524	26.5 K to 32.5 K (+22.62 %)
Apr 24 2020	RGEN	REPLIGEN CORP	BARTHELEMY NICOLAS	Director	Option Exercise	M	42.07	1,652	69,500	0
Apr 24 2020	RGEN	REPLIGEN CORP	BARTHELEMY NICOLAS	Director	Sell	S	109.99	2,688	295,653	3,037	5.7 K to 3 K (-46.95 %)
Apr 24 2020	RGEN	REPLIGEN CORP	BARTHELEMY NICOLAS	Director	Buy	M	42.07	1,652	69,500	5,725	4.1 K to 5.7 K (+40.56 %)
Apr 22 2020	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Option Exercise	M	3.30	11,800	38,940	0
Apr 22 2020	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Option Exercise	M	3.30	8,200	27,060	11,800
Apr 22 2020	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Buy	M	3.30	11,800	38,940	120,834	109 K to 120.8 K (+10.82 %)
Apr 22 2020	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Sell	S	104.42	8,998	939,571	109,034	118 K to 109 K (-7.62 %)
Apr 22 2020	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Sell	S	104.98	3,202	336,146	118,032	121.2 K to 118 K (-2.64 %)
Apr 22 2020	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Buy	M	3.30	8,200	27,060	121,234	113 K to 121.2 K (+7.25 %)
Apr 06 2020	RGEN	REPLIGEN CORP	BARTHELEMY NICOLAS	Director	Option Exercise	M	42.07	1,652	69,500	1,652
Apr 06 2020	RGEN	REPLIGEN CORP	BARTHELEMY NICOLAS	Director	Sell	S	99.99	2,688	268,773	4,073	6.8 K to 4.1 K (-39.76 %)
Apr 06 2020	RGEN	REPLIGEN CORP	BARTHELEMY NICOLAS	Director	Buy	M	42.07	1,652	69,500	6,761	5.1 K to 6.8 K (+32.34 %)
Mar 26 2020	RGEN	REPLIGEN CORP	Cox John	Director	Sell	S	96.72	1,858	179,706	923	2.8 K to 923 (-66.81 %)
Mar 20 2020	RGEN	REPLIGEN CORP	Cox John	Director	Option Exercise	M	42.07	3,304	138,999	0
Mar 20 2020	RGEN	REPLIGEN CORP	Cox John	Director	Option Exercise	M	38.76	2,434	94,342	0
Mar 20 2020	RGEN	REPLIGEN CORP	Cox John	Director	Option Exercise	M	26.12	3,366	87,920	0
Mar 20 2020	RGEN	REPLIGEN CORP	Cox John	Director	Option Exercise	M	41.19	3,632	149,602	0
Mar 20 2020	RGEN	REPLIGEN CORP	Cox John	Director	Option Exercise	M	12.91	14,000	180,740	0
Mar 20 2020	RGEN	REPLIGEN CORP	Cox John	Director	Sell	S	97.17	1,016	98,725	2,781	3.8 K to 2.8 K (-26.76 %)
Mar 20 2020	RGEN	REPLIGEN CORP	Cox John	Director	Sell	S	96.45	1,187	114,486	3,797	5 K to 3.8 K (-23.82 %)
Mar 20 2020	RGEN	REPLIGEN CORP	Cox John	Director	Sell	S	95.13	24,533	2,333,824	4,984	29.5 K to 5 K (-83.11 %)
Mar 20 2020	RGEN	REPLIGEN CORP	Cox John	Director	Buy	M	42.07	3,304	138,999	29,517	26.2 K to 29.5 K (+12.60 %)
Mar 20 2020	RGEN	REPLIGEN CORP	Cox John	Director	Buy	M	38.76	2,434	94,342	26,213	23.8 K to 26.2 K (+10.24 %)
Mar 20 2020	RGEN	REPLIGEN CORP	Cox John	Director	Buy	M	26.12	3,366	87,920	23,779	20.4 K to 23.8 K (+16.49 %)
Mar 20 2020	RGEN	REPLIGEN CORP	Cox John	Director	Buy	M	41.19	3,632	149,602	20,413	16.8 K to 20.4 K (+21.64 %)
Mar 20 2020	RGEN	REPLIGEN CORP	Cox John	Director	Buy	M	12.91	14,000	180,740	16,781	2.8 K to 16.8 K (+503.42 %)
Mar 18 2020	RGEN	REPLIGEN CORP	RYAN THOMAS F JR	Director	Option Exercise	M	42.07	500	21,035	0
Mar 18 2020	RGEN	REPLIGEN CORP	RYAN THOMAS F JR	Director	Option Exercise	M	38.76	500	19,380	1,934
Mar 18 2020	RGEN	REPLIGEN CORP	RYAN THOMAS F JR	Director	Sell	S	91.48	1,000	91,480	1,923	2.9 K to 1.9 K (-34.21 %)
Mar 18 2020	RGEN	REPLIGEN CORP	RYAN THOMAS F JR	Director	Buy	M	42.07	500	21,035	2,923	2.4 K to 2.9 K (+20.64 %)
Mar 18 2020	RGEN	REPLIGEN CORP	RYAN THOMAS F JR	Director	Buy	M	38.76	500	19,380	2,423	1.9 K to 2.4 K (+26.00 %)
Mar 05 2020	RGEN	REPLIGEN CORP	Snodgres Jon	Chief Financial Off ...	Sell	S	90.39	1,045	94,458	36,127	37.2 K to 36.1 K (-2.81 %)
Mar 05 2020	RGEN	REPLIGEN CORP	Snodgres Jon	Chief Financial Off ...	Sell	S	88.18	610	53,790	37,172	37.8 K to 37.2 K (-1.61 %)
Mar 05 2020	RGEN	REPLIGEN CORP	RYAN THOMAS F JR	Director	Option Exercise	M	42.07	2,804	117,964	500
Mar 05 2020	RGEN	REPLIGEN CORP	RYAN THOMAS F JR	Director	Option Exercise	M	41.19	1,992	82,050	0
Mar 05 2020	RGEN	REPLIGEN CORP	RYAN THOMAS F JR	Director	Sell	S	88.82	4,796	425,981	1,923	6.7 K to 1.9 K (-71.38 %)
Mar 05 2020	RGEN	REPLIGEN CORP	RYAN THOMAS F JR	Director	Buy	M	42.07	2,804	117,964	6,719	3.9 K to 6.7 K (+71.62 %)
Mar 05 2020	RGEN	REPLIGEN CORP	RYAN THOMAS F JR	Director	Buy	M	41.19	1,992	82,050	3,915	1.9 K to 3.9 K (+103.59 %)
Mar 05 2020	RGEN	REPLIGEN CORP	RYAN THOMAS F JR	Director	Sell	S	85.72	2,225	190,727	1,923	4.1 K to 1.9 K (-53.64 %)
Mar 05 2020	RGEN	REPLIGEN CORP	KURIYEL RALF	Senior VP, R&D	Sell	S	90.99	1,905	173,336	26,524	28.4 K to 26.5 K (-6.70 %)
Mar 05 2020	RGEN	REPLIGEN CORP	KURIYEL RALF	Senior VP, R&D	Sell	S	90.08	650	58,552	28,429	29.1 K to 28.4 K (-2.24 %)
Mar 05 2020	RGEN	REPLIGEN CORP	KURIYEL RALF	Senior VP, R&D	Sell	S	88.35	450	39,758	29,079	29.5 K to 29.1 K (-1.52 %)
Mar 05 2020	RGEN	REPLIGEN CORP	Cox John	Director	Option Exercise	M	12.91	10,000	129,100	14,000
Mar 05 2020	RGEN	REPLIGEN CORP	Cox John	Director	Sell	S	93.39	10,000	933,900	2,781	12.8 K to 2.8 K (-78.24 %)
Mar 05 2020	RGEN	REPLIGEN CORP	Cox John	Director	Buy	M	12.91	10,000	129,100	12,781	2.8 K to 12.8 K (+359.58 %)
Mar 05 2020	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Sell	S	90.13	12,300	1,108,599	230,241	242.5 K to 230.2 K (-5.07 %)
Mar 05 2020	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Sell	S	88.56	100	8,856	242,541	242.6 K to 242.5 K (-0.04 %)
Mar 05 2020	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Sell	S	88.20	2,090	184,338	242,641	244.7 K to 242.6 K (-0.85 %)
Mar 02 2020	RGEN	REPLIGEN CORP	Snodgres Jon	Chief Financial Off ...	Option Exercise	A	44.13	4,571	201,718	4,571
Mar 02 2020	RGEN	REPLIGEN CORP	Snodgres Jon	Chief Financial Off ...	Grant	A	0.00	4,686	0	37,782	33.1 K to 37.8 K (+14.16 %)
Mar 02 2020	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Option Exercise	A	86.10	18,128	1,560,821	18,128
Mar 02 2020	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Grant	A	0.00	18,583	0	244,731	226.1 K to 244.7 K (+8.22 %)
Mar 02 2020	RGEN	REPLIGEN CORP	KURIYEL RALF	Senior VP, R&D	Option Exercise	A	86.10	3,137	270,096	3,137
Mar 02 2020	RGEN	REPLIGEN CORP	KURIYEL RALF	Senior VP, R&D	Grant	A	0.00	3,216	0	29,529	26.3 K to 29.5 K (+12.22 %)
Feb 27 2020	RGEN	REPLIGEN CORP	Snodgres Jon	Chief Financial Off ...	Sell	S	86.11	946	81,460	31,096	32 K to 31.1 K (-2.95 %)
Feb 27 2020	RGEN	REPLIGEN CORP	Snodgres Jon	Chief Financial Off ...	Sell	S	86.86	154	13,376	32,042	32.2 K to 32 K (-0.48 %)
Feb 27 2020	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Option Exercise	M	16.55	10,210	168,976	7,917
Feb 27 2020	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Option Exercise	M	32.40	11,735	380,214	53,240
Feb 27 2020	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Sell	S	86.10	1,594	137,243	226,148	227.7 K to 226.1 K (-0.70 %)
Feb 27 2020	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Sell	S	86.86	1,881	163,384	227,742	229.6 K to 227.7 K (-0.82 %)
Feb 27 2020	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Buy	M	16.55	10,210	168,976	229,623	219.4 K to 229.6 K (+4.65 %)
Feb 27 2020	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Sell	S	90.22	1,624	146,517	219,413	221 K to 219.4 K (-0.73 %)
Feb 27 2020	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Sell	S	91.66	8,412	771,044	221,037	229.4 K to 221 K (-3.67 %)
Feb 27 2020	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Sell	S	92.34	1,699	156,886	229,449	231.1 K to 229.4 K (-0.74 %)
Feb 27 2020	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Buy	M	32.40	11,735	380,214	231,148	219.4 K to 231.1 K (+5.35 %)
Feb 27 2020	RGEN	REPLIGEN CORP	KURIYEL RALF	Senior VP, R&D	Sell	S	86.60	195	16,887	26,313	26.5 K to 26.3 K (-0.74 %)
Feb 26 2020	RGEN	REPLIGEN CORP	Cox John	Director	Sell	S	92.76	4,355	403,970	2,781	7.1 K to 2.8 K (-61.03 %)
Feb 26 2020	RGEN	REPLIGEN CORP	Cox John	Director	Sell	S	94.85	100	9,485	7,136	7.2 K to 7.1 K (-1.38 %)
Feb 24 2020	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Sell	S	97.52	1,849	180,314	113,034	114.9 K to 113 K (-1.61 %)
Feb 24 2020	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Sell	S	99.12	906	89,803	114,883	115.8 K to 114.9 K (-0.78 %)
Feb 24 2020	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Sell	S	99.85	945	94,358	115,789	116.7 K to 115.8 K (-0.81 %)
Feb 24 2020	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Sell	S	101.06	300	30,318	116,734	117 K to 116.7 K (-0.26 %)
Dec 18 2019	RGEN	REPLIGEN CORP	KURIYEL RALF	Senior VP, R&D	Payment of Exercise	F	90.43	295	26,677	26,508	26.8 K to 26.5 K (-1.10 %)
Dec 09 2019	RGEN	REPLIGEN CORP	Snodgres Jon	Chief Financial Off ...	Option Exercise	M	26.05	1,957	50,980	3,170
Dec 09 2019	RGEN	REPLIGEN CORP	Snodgres Jon	Chief Financial Off ...	Option Exercise	M	24.50	2,000	49,000	0
Dec 09 2019	RGEN	REPLIGEN CORP	Snodgres Jon	Chief Financial Off ...	Buy	M	26.05	1,957	50,980	32,196	30.2 K to 32.2 K (+6.47 %)
Dec 09 2019	RGEN	REPLIGEN CORP	Snodgres Jon	Chief Financial Off ...	Buy	M	24.50	2,000	49,000	30,239	28.2 K to 30.2 K (+7.08 %)
Sep 23 2019	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Option Exercise	M	16.55	20,000	331,000	18,127
Sep 23 2019	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Sell	S	83.72	452	37,842	219,413	219.9 K to 219.4 K (-0.21 %)
Sep 23 2019	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Sell	S	83.01	2,510	208,349	219,865	222.4 K to 219.9 K (-1.13 %)
Sep 23 2019	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Sell	S	81.82	638	52,198	222,375	223 K to 222.4 K (-0.29 %)
Sep 23 2019	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Buy	M	16.55	20,000	331,000	223,013	203 K to 223 K (+9.85 %)
Sep 11 2019	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Sell	S	90.31	36	3,251	203,013	203 K to 203 K (-0.02 %)
Sep 11 2019	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Sell	S	89.27	288	25,710	203,049	203.3 K to 203 K (-0.14 %)
Sep 11 2019	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Sell	S	86.26	222	19,150	203,337	203.6 K to 203.3 K (-0.11 %)
Sep 11 2019	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Sell	S	84.64	740	62,632	203,559	204.3 K to 203.6 K (-0.36 %)
Sep 11 2019	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Sell	S	83.05	1,751	145,419	204,299	206.1 K to 204.3 K (-0.85 %)
Sep 11 2019	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Sell	S	82.15	4,926	404,684	206,050	211 K to 206.1 K (-2.33 %)
Sep 11 2019	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Sell	S	81.26	4,131	335,676	210,976	215.1 K to 211 K (-1.92 %)
Jul 17 2019	RGEN	REPLIGEN CORP	Snodgres Jon	Chief Financial Off ...	Payment of Exercise	F	85.95	295	25,355	28,239	28.5 K to 28.2 K (-1.03 %)
Jun 19 2019	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Option Exercise	M	4.96	20,000	99,200	0
Jun 19 2019	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Sell	S	77.35	1,295	100,168	117,034	118.3 K to 117 K (-1.09 %)
Jun 19 2019	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Buy	M	4.96	20,000	99,200	118,329	98.3 K to 118.3 K (+20.34 %)
May 28 2019	RGEN	REPLIGEN CORP	COOPER GLENN L MD	Director	Sell	S	67.53	266	17,963	35,709	36 K to 35.7 K (-0.74 %)
May 28 2019	RGEN	REPLIGEN CORP	COOPER GLENN L MD	Director	Sell	S	66.91	4,734	316,752	35,975	40.7 K to 36 K (-11.63 %)
May 17 2019	RGEN	REPLIGEN CORP	RYAN THOMAS F JR	Director	Option Exercise	A	67.71	2,109	142,800	2,109
May 17 2019	RGEN	REPLIGEN CORP	RYAN THOMAS F JR	Director	Grant	A	0.00	923	0	4,148	3.2 K to 4.1 K (+28.62 %)
May 17 2019	RGEN	REPLIGEN CORP	Cox John	Director	Option Exercise	A	67.71	2,109	142,800	2,109
May 17 2019	RGEN	REPLIGEN CORP	Cox John	Director	Grant	A	0.00	923	0	7,236	6.3 K to 7.2 K (+14.62 %)
May 17 2019	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Option Exercise	A	67.71	2,953	199,948	2,953
May 17 2019	RGEN	REPLIGEN CORP	DAWES KAREN A	Director	Grant	A	0.00	1,292	0	98,329	97 K to 98.3 K (+1.33 %)
May 17 2019	RGEN	REPLIGEN CORP	COOPER GLENN L MD	Director	Option Exercise	A	67.71	2,109	142,800	2,109
May 17 2019	RGEN	REPLIGEN CORP	COOPER GLENN L MD	Director	Grant	A	0.00	923	0	40,709	39.8 K to 40.7 K (+2.32 %)
May 17 2019	RGEN	REPLIGEN CORP	BARTHELEMY NICOLAS	Director	Option Exercise	A	67.71	2,109	142,800	2,109
May 17 2019	RGEN	REPLIGEN CORP	BARTHELEMY NICOLAS	Director	Grant	A	0.00	923	0	5,109	4.2 K to 5.1 K (+22.05 %)
May 17 2019	RGEN	REPLIGEN CORP	MUIR GLENN P	Director	Option Exercise	A	67.71	2,109	142,800	2,109
May 17 2019	RGEN	REPLIGEN CORP	MUIR GLENN P	Director	Grant	A	0.00	923	0	5,378	4.5 K to 5.4 K (+20.72 %)
May 15 2019	RGEN	REPLIGEN CORP	Snodgres Jon	Chief Financial Off ...	Grant	A	0.00	8,000	0	28,534	20.5 K to 28.5 K (+38.96 %)
Mar 27 2019	RGEN	REPLIGEN CORP	Snodgres Jon	Chief Financial Off ...	Sell	S	59.05	1,009	59,581	20,534	21.5 K to 20.5 K (-4.68 %)
Mar 27 2019	RGEN	REPLIGEN CORP	Snodgres Jon	Chief Financial Off ...	Sell	S	58.45	5,458	319,020	21,543	27 K to 21.5 K (-20.21 %)
Mar 20 2019	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Sell	S	60.91	500	30,457	215,107	215.6 K to 215.1 K (-0.23 %)
Mar 20 2019	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Sell	S	60.45	4,009	242,363	215,607	219.6 K to 215.6 K (-1.83 %)
Mar 20 2019	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Sell	S	59.24	10,041	594,813	219,616	229.7 K to 219.6 K (-4.37 %)
Mar 05 2019	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Sell	S	58.50	13,000	760,500	229,657	242.7 K to 229.7 K (-5.36 %)
Mar 05 2019	RGEN	REPLIGEN CORP	KURIYEL RALF	Senior VP, R&D	Sell	S	58.53	2,240	131,107	18,803	21 K to 18.8 K (-10.64 %)
Mar 05 2019	RGEN	REPLIGEN CORP	KURIYEL RALF	Senior VP, R&D	Grant	A	0.00	4,700	0	21,043	16.3 K to 21 K (+28.76 %)
Mar 05 2019	RGEN	REPLIGEN CORP	Snodgres Jon	Chief Financial Off ...	Sell	S	58.52	2,645	154,785	27,001	29.6 K to 27 K (-8.92 %)
Mar 05 2019	RGEN	REPLIGEN CORP	Snodgres Jon	Chief Financial Off ...	Grant	A	0.00	4,700	0	29,646	24.9 K to 29.6 K (+18.84 %)
Mar 04 2019	RGEN	REPLIGEN CORP	Snodgres Jon	Chief Financial Off ...	Option Exercise	A	59.52	5,653	336,467	5,653
Mar 04 2019	RGEN	REPLIGEN CORP	Snodgres Jon	Chief Financial Off ...	Sell	S	58.88	1,875	110,400	24,946	26.8 K to 24.9 K (-6.99 %)
Mar 04 2019	RGEN	REPLIGEN CORP	Snodgres Jon	Chief Financial Off ...	Grant	A	0.00	5,922	0	26,821	20.9 K to 26.8 K (+28.34 %)
Mar 04 2019	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Option Exercise	A	59.52	21,651	1,288,668	21,651
Mar 04 2019	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Sell	S	59.01	7,475	441,100	242,657	250.1 K to 242.7 K (-2.99 %)
Mar 04 2019	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Grant	A	0.00	22,681	0	250,132	227.5 K to 250.1 K (+9.97 %)
Mar 04 2019	RGEN	REPLIGEN CORP	KURIYEL RALF	Senior VP, R&D	Option Exercise	A	59.52	4,042	240,580	4,042
Mar 04 2019	RGEN	REPLIGEN CORP	KURIYEL RALF	Senior VP, R&D	Sell	S	59.16	185	10,945	16,343	16.5 K to 16.3 K (-1.12 %)
Mar 04 2019	RGEN	REPLIGEN CORP	KURIYEL RALF	Senior VP, R&D	Grant	A	0.00	4,234	0	16,528	12.3 K to 16.5 K (+34.44 %)
Dec 20 2018	RGEN	REPLIGEN CORP	KURIYEL RALF	Senior VP, R&D	Sell	S	54.44	311	16,931	12,294	12.6 K to 12.3 K (-2.47 %)
Nov 28 2018	RGEN	REPLIGEN CORP	Snodgres Jon	CFO	Option Exercise	M	26.05	10,253	267,091	5,127
Nov 28 2018	RGEN	REPLIGEN CORP	Snodgres Jon	CFO	Option Exercise	M	32.40	6,055	196,182	12,110
Nov 28 2018	RGEN	REPLIGEN CORP	Snodgres Jon	CFO	Option Exercise	M	24.50	4,000	98,000	2,000
Nov 28 2018	RGEN	REPLIGEN CORP	Snodgres Jon	CFO	Option Exercise	M	26.20	11,445	299,859	0
Nov 28 2018	RGEN	REPLIGEN CORP	Snodgres Jon	CFO	Sell	S	63.49	31,753	2,015,915	20,899	52.7 K to 20.9 K (-60.31 %)
Nov 28 2018	RGEN	REPLIGEN CORP	Snodgres Jon	CFO	Buy	M	26.05	10,253	267,091	52,652	42.4 K to 52.7 K (+24.18 %)
Nov 28 2018	RGEN	REPLIGEN CORP	Snodgres Jon	CFO	Buy	M	32.40	6,055	196,182	42,399	36.3 K to 42.4 K (+16.66 %)
Nov 28 2018	RGEN	REPLIGEN CORP	Snodgres Jon	CFO	Buy	M	24.50	4,000	98,000	36,344	32.3 K to 36.3 K (+12.37 %)
Nov 28 2018	RGEN	REPLIGEN CORP	Snodgres Jon	CFO	Buy	M	26.20	11,445	299,859	32,344	20.9 K to 32.3 K (+54.76 %)
Nov 06 2018	RGEN	REPLIGEN CORP	RYAN THOMAS F JR	Director	Sell	S	65.75	1,763	115,920	3,225	5 K to 3.2 K (-35.34 %)
Sep 12 2018	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Option Exercise	M	16.55	11,873	196,498	38,127
Sep 12 2018	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Sell	S	57.71	27,566	1,590,809	227,451	255 K to 227.5 K (-10.81 %)
Sep 12 2018	RGEN	REPLIGEN CORP	Hunt Anthony	Chief Executive Off ...	Buy	M	16.55	11,873	196,498	255,017	243.1 K to 255 K (+4.88 %)
Aug 31 2018	RGEN	REPLIGEN CORP	BARTHELEMY NICOLAS	Director	Option Exercise	M	41.19	1,992	82,050	0
Aug 31 2018	RGEN	REPLIGEN CORP	BARTHELEMY NICOLAS	Director	Option Exercise	M	38.76	2,434	94,342	0
Aug 31 2018	RGEN	REPLIGEN CORP	BARTHELEMY NICOLAS	Director	Sell	S	54.44	6,580	358,196	4,186	10.8 K to 4.2 K (-61.12 %)
Aug 31 2018	RGEN	REPLIGEN CORP	BARTHELEMY NICOLAS	Director	Buy	M	41.19	1,992	82,050	10,766	8.8 K to 10.8 K (+22.70 %)
Aug 31 2018	RGEN	REPLIGEN CORP	BARTHELEMY NICOLAS	Director	Buy	M	38.76	2,434	94,342	8,774	6.3 K to 8.8 K (+38.39 %)
Aug 29 2018	RGEN	REPLIGEN CORP	Snodgres Jon	CFO	Sell	S	52.79	14,460	763,359	20,899	35.4 K to 20.9 K (-40.89 %)

Page: < prev 1 2 3 4 5 6 ... 7 next >